The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled trials before they’re licensed for use, raising urgent questions about the system used to clear updated Covid-19 boosters each respiratory virus season.

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not needed to conduct additional tests on each year’s updated vaccine. It's similar to the way the annual flu shot is updated to target the newest influenza strains,

The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have risk factors for severe COVID-19.

Here's what the day looks like, including who will speak: We're no longer posting updates on the inquiry today, but you can watch the proceedings live at the top of this page. The COVID vaccine ...

He is also demanding an inquiry into whether records were ... and other information relating to the COVID-19 pandemic and the vaccines must be thoroughly investigated.” Johnson and other ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical data is needed for healthy adults and kids.

The head of the Covid-19 Royal Commission of Inquiry has criticised the scale of lockdowns and vaccine mandates, suggesting they were too broad and too harsh. Epidemiologist Professor Tony Blakely ...

Families of those harmed by Covid vaccines told the UK Covid Inquiry they were forced to support each other during the pandemic because there was no other help. Kate Scott, who represents the ...

As the Trump administration moves to limit COVID booster vaccines for some, here's what to know about the latest variant NB.1.8.1 and its symptoms.